Results 71 to 80 of about 234,795 (273)
Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center
JEADV Clinical Practice, EarlyView.ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres +4 more
wiley +1 more source
MicroRNA profile in patients with plaque psoriasis and palmoplantar pustular psoriasis
Vestnik Dermatologii i VenerologiiBackground: Palmoplantar pustular psoriasis (PPPP) is considered a clinically and pathogenetically distinct form of psoriasis; however, its molecular patterns remain insufficiently understood.
Evgeniya V. Turchik +6 more
doaj +1 more source
The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis [PDF]
, 2005 Background: Chronic plaque-type psoriasis is a major dermatosis, but a significant question is still unanswered: What defines severity in chronic plaque-type psoriasis?
Schmitt, Jochen, Wozel, Gottfried
core +1 more source
JEADV Clinical Practice, EarlyView.In this prospective observational cohort study, 34 patients with moderate‐to‐severe psoriasis received biologic therapy (anti‐TNF‐α, anti‐IL‐12/23, or anti‐IL‐17) for 6 months. Carotid intima–media thickness decreased significantly in the overall cohort (p < 0.01), with the greatest reductions in the anti‐IL‐17 and anti‐IL‐12/23 groups.
Harika Ödemiş +6 more
wiley +1 more source
Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% [PDF]
, 2012 Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders.
Schöllmann, C. +3 more
core +1 more source
JEADV Clinical Practice, EarlyView.This post‐hoc analysis of the Greek real‐world ReSOLVE study compared clinical and patient‐reported outcomes by body weight (< 100 kg vs. ≥ 100 kg) and BMI over 52 weeks. Patients ≥ 100 kg showed delayed PASI and sPGA responses at W24 and W52, while BMI had little impact. Quality‐of‐life improvements were substantial, though early gains were smaller in
Pantelis Panagakis +12 more
wiley +1 more source
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
European Medical Journal Dermatology, 2020 With the recent advancements of biologic therapies that block IL-23, there is increasing need for analysis of which biologics are most efficacious in treatment of plaque psoriasis.
Nicole L. Bolick +2 more
doaj
Is risankizumab as needed administration a good option for patients with plaque psoriasis?
, 2022 Is risankizumab as needed administration a good option for patients with plaque ...
Girolomoni, G +7 more
core +1 more source
Eczema‐Like Amelanotic Melanoma: A Diagnostic Challenge
JEADV Clinical Practice, EarlyView.ABSTRACT Amelanotic melanoma (AM) is a rare and aggressive variant of cutaneous melanoma characterised by the absence of pigmentation, often leading to delayed diagnosis due to its ability to mimic benign inflammatory or neoplastic conditions. We report the case of a 68‐year‐old woman presenting with a slowly enlarging, erythematous, mildly scaling ...
Agata Janowska +8 more
wiley +1 more source
Calcitriol in the Management of Moderate to Severe Plaque Psoriasis
, 2009 Psoriasis is a chronic inflammatory cell-mediated disease affecting skin and joints, histologically characterized by epidermal hyperplasia and abnormal differentiation of keratinocytes.
Sergio Chimenti +2 more
core +1 more source